Form D · Other Health Care
ATROPOS HEALTH INC
New York, NY · CIK 0001943427
Offering snapshot reported May 31, 2024 · SEC filing
- Reported sold
- $33M Offering amount: $33M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 31, 2024 | Initial | $32,999,989 | No comparison | 7 | SEC filing |
| Aug 11, 2023 | Initial | $3,325,314 | No comparison | 8 | SEC filing |
| Aug 18, 2022 | Initial | $8,000,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-514845
Source: Form D, filed May 31, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Bettonville | Director |
| James Breyer | Director |
| Saurabh Gombar | Executive |
| Brigham Hyde | Director, Executive |
| Neil Sanghavi | Executive |
| Nigam Shah | Director |
| Mike Spadafore | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
169 Madison Avenue Suite 2242
New York, NY, 10016
New York, NY, 10016